What does this research mean for the field?

WDR4 is a prognostic biomarker in hepatocellular carcinoma (HCC) and is associated with immune infiltration and immunotherapeutic potential. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate WDR4 as a potential biomarker for diagnosis and prognosis in hepatocellular carcinoma.

March 2, 2026Open Access

WDR4 is a Potential Indicator of Clinical Diagnostics, Prognosis, and Immunotherapy in Hepatocellular Carcinoma (HCC)

Puntos clave

To evaluate WDR4 as a potential biomarker for diagnosis and prognosis in hepatocellular carcinoma.
Analyzed WDR4 expression levels in hepatocellular carcinoma tissues.
Assessed correlation with immune cell markers like CD68 and PD-L1.
Examined the relationship between WDR4 and immune infiltration.
WDR4 expression was significantly elevated in HCC tissues.
Positive correlation found between WDR4 and CD68, indicating immune cell infiltration.
WDR4 levels positively correlated with PD-L1, highlighting its role in immunotherapy.

Resumen

WDR4 shows elevated expression in HCC tissues and is associated with immune infiltration, establishing it as a prognostic biomarker in HCC. Furthermore, the positive correlation observed between WDR4 and CD68, as well as PD-L1 (CD274), underscores its potential as a guiding factor in immunotherapeutic approaches for HCC.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Yang et al. (Mon,) studied this question.

synapsesocial.com/papers/69a52e45f1e85e5c73bf1c68 https://doi.org/https://doi.org/10.31083/fbl45764

Me gusta

Guardar

Ver artículo completo